¿Es pentapeptide-61 seguro durante el embarazo?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for pentapeptide-61 was identified in available regulatory sources. No peer-reviewed reproductive or developmental toxicity data specific to pentapeptide-61 were found. Peptides of this size are generally polar and have low systemic absorption after topical use, so default hazard/mechanism/exposure ratings are 0. Sources consulted: ECHA Annex VI (no entry), CIR (no specific assessment), PubMed (no reproductive/developmental studies found), CosIng/PubChem entries show cosmetic peptide identity only.
Related ingredients
Frequently asked questions
- ¿Es pentapeptide-61 seguro durante el embarazo?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for pentapeptide-61 was identified in available regulatory sources. No peer-reviewed reproductive or developmental toxicity data specific to pentapeptide-61 were found. Peptides of this size are generally polar and have low systemic absorption after topical use, so default hazard/mechanism/exposure ratings are 0. Sources consulted: ECHA Annex VI (no entry), CIR (no specific assessment), PubMed (no reproductive/developmental studies found), CosIng/PubChem entries show cosmetic peptide identity only.
- ¿Es pentapeptide-61 seguro durante la lactancia?
- No evidence of reproductive or lactation-specific toxicity or mechanism for pentapeptide-61 in SCCS/CIR/ECHA or peer-reviewed literature. No harmonised classification. Given expected low dermal absorption of short peptides, systemic exposure to lactating parent and transfer into breast milk is considered negligible based on available information.
- ¿Es pentapeptide-61 seguro para la piel del bebé?
- No infant-specific safety or developmental toxicity data identified. Peptides this size are generally poorly absorbed through intact adult skin (adult exposure rated 0), but infant skin has higher permeability; following guidance, exposure for baby skin is increased by +1 (to 1) due to possible measurable absorption in infants. No mechanistic or hazard evidence for reproductive/developmental effects specific to infants was found.
- ¿Cómo puntúa VeriMom a pentapeptide-61?
- VeriMom puntúa pentapeptide-61 en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a pentapeptide-61 en el embarazo?
- Consulta nuestra lista de alternativas seguras a pentapeptide-61 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.